The Brazil Contraceptive Devices Market is estimated to be valued at $0.355 billion in the year 2018 and is expected to grow at a CAGR of 7.92% from 2018 to 2024. Contraceptive Devices are various devices used to prevent pregnancy, which includes the diaphragm, condom, intrauterine devices, etc. Nowadays in teenagers, pregnancies are at higher risk of poor outcomes. Comprehensive sex education and access to birth control decrease the rate of unwanted pregnancies in this age group.
Brazil Contraceptive Devices Market Share:
Compared to the past years, Contraceptive Devices has undergone a predominant change in the markets of Brazil. IUD and Condoms are expected to have the highest growth rate due to the increasing number of unwanted pregnancies and are comfortable and very useful in birth controlling process.
Brazil Contraceptive Devices Market Size:
There is a wide range of fields in Contraceptive Devices are used, such as Diaphragms, Cervical caps, Sponges, Vaginal rings, Condoms, IUD, and implants. As there are significant applications, the market size
Brazil Contraceptive Devices Market Growth:
The necessity to avoid unwanted pregnancies, especially in teenage women, Increasing incidences of STDs, Rapid population rise globally, Potential non-contraception health benefits, such as treatment for excessive menstrual bleeding, menstrual pain, and acne Government initiatives are the major factors that are driving the market growth.
Brazil Contraceptive Devices Market Industry Analysis:
Brazil Contraceptive Devices Market is segmented based on type, and gender. Based on Type, the market is segmented into as Diaphragms, Cervical caps, Sponges, Vaginal rings, Condoms, IUD, and implants. Based on Gender, the market is segmented into male and female.
Brazil Contraceptive Devices Market Outlook:
Growing geriatric population across Brazil coupled with rising incidence of lifestyle disorders will induce infertility eventually reducing the demand for contraception products. Moreover, concerns regarding the side effects of products can negatively impact the product demand in future.
Brazil Contraceptive Devices Market Trends:
U.S FDA approves Pfizer’s bosulif for the treatment of patients with newly diagnosed PH+ chronic myelogenous leukaemia. Johnson & Johnson Company announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments.
Brazil Contraceptive Devices Market Research report includes:
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.